224 related articles for article (PubMed ID: 34440346)
1. TWEAKing the Hippocampus: The Effects of TWEAK on the Genomic Fabric of the Hippocampus in a Neuropsychiatric Lupus Mouse Model.
Iacobas DA; Wen J; Iacobas S; Putterman C; Schwartz N
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440346
[TBL] [Abstract][Full Text] [Related]
2. Remodeling of Neurotransmission, Chemokine, and PI3K-AKT Signaling Genomic Fabrics in Neuropsychiatric Systemic Lupus Erythematosus.
Iacobas D; Wen J; Iacobas S; Schwartz N; Putterman C
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33578738
[TBL] [Abstract][Full Text] [Related]
3. TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.
Wen J; Doerner J; Weidenheim K; Xia Y; Stock A; Michaelson JS; Baruch K; Deczkowska A; Gulinello M; Schwartz M; Burkly LC; Putterman C
J Autoimmun; 2015 Jun; 60():40-50. PubMed ID: 25911200
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.
Wen J; Xia Y; Stock A; Michaelson JS; Burkly LC; Gulinello M; Putterman C
J Autoimmun; 2013 Jun; 43():44-54. PubMed ID: 23578591
[TBL] [Abstract][Full Text] [Related]
5. Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice.
Wen J; Chen CH; Stock A; Doerner J; Gulinello M; Putterman C
Brain Behav Immun; 2016 May; 54():27-37. PubMed ID: 26721417
[TBL] [Abstract][Full Text] [Related]
6. Fn14 deficiency protects lupus-prone mice from histological lupus erythematosus-like skin inflammation induced by ultraviolet light.
Doerner J; Chalmers SA; Friedman A; Putterman C
Exp Dermatol; 2016 Dec; 25(12):969-976. PubMed ID: 27305603
[TBL] [Abstract][Full Text] [Related]
7. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
[TBL] [Abstract][Full Text] [Related]
8. Is serum TWEAK a useful biomarker of neuropsychiatric systemic lupus erythematosus?
Balajkova V; Olejarova M; Moravcova R; Kozelek P; Posmurova M; Hulejova H; Senolt L
Physiol Res; 2020 Apr; 69(2):339-346. PubMed ID: 32199014
[TBL] [Abstract][Full Text] [Related]
9. TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus.
Doerner JL; Wen J; Xia Y; Paz KB; Schairer D; Wu L; Chalmers SA; Izmirly P; Michaelson JS; Burkly LC; Friedman AJ; Putterman C
J Invest Dermatol; 2015 Aug; 135(8):1986-1995. PubMed ID: 25826425
[TBL] [Abstract][Full Text] [Related]
10. TWEAK as a target for therapy in systemic lupus erythematosus.
Leng RX; Pan HF; Qin WZ; Wang C; Chen LL; Tao JH; Ye DQ
Mol Biol Rep; 2011 Jan; 38(1):587-92. PubMed ID: 20358293
[TBL] [Abstract][Full Text] [Related]
11. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus.
Zhao Z; Burkly LC; Campbell S; Schwartz N; Molano A; Choudhury A; Eisenberg RA; Michaelson JS; Putterman C
J Immunol; 2007 Dec; 179(11):7949-58. PubMed ID: 18025243
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway.
Stock AD; Wen J; Putterman C
Front Immunol; 2013 Dec; 4():484. PubMed ID: 24400009
[TBL] [Abstract][Full Text] [Related]
13. Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway.
Min HK; Kim SM; Park JS; Byun JK; Lee J; Kwok SK; Park YW; Cho ML; Park SH
J Transl Med; 2016 Apr; 14():98. PubMed ID: 27098560
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of suppressor of cytokine signaling 1 mediates the profibrotic effect of TWEAK/Fn14 signaling on kidney cells.
Chen J; Jia F; Ren K; Luo M; Min X; Wang P; Xiao S; Xia Y
Cell Signal; 2020 Jul; 71():109615. PubMed ID: 32217132
[TBL] [Abstract][Full Text] [Related]
15. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
[TBL] [Abstract][Full Text] [Related]
16. The blood-brain barrier, TWEAK, and neuropsychiatric involvement in human systemic lupus erythematosus and primary Sjögren's syndrome.
Lauvsnes MB; Tjensvoll AB; Maroni SS; Kvivik I; Grimstad T; Greve OJ; Harboe E; Gøransson LG; Putterman C; Omdal R
Lupus; 2018 Nov; 27(13):2101-2111. PubMed ID: 30282561
[TBL] [Abstract][Full Text] [Related]
17. FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus.
Shi D; Tian T; Yao S; Cao K; Zhu X; Zhang M; Wen S; Li L; Shi M; Zhou H
Brain Behav Immun; 2018 May; 70():293-304. PubMed ID: 29548997
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal microglia CD40 mediates NPSLE cognitive dysfunction in mice.
Qiao X; Wang H; Lu L; Chen J; Cheng Q; Guo M; Hou Y; Dou H
J Neuroimmunol; 2021 Aug; 357():577620. PubMed ID: 34062352
[TBL] [Abstract][Full Text] [Related]
19. Status of TWEAK DNA methylation and mRNA expression in systemic lupus erythematosus.
Liao L; Li S; Upreti B; Wang X; Yang Y; Lou X; Li L; Cui R; Liu S; Cheng Y; Xu J
Lupus; 2023 Feb; 32(2):171-179. PubMed ID: 36418949
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of TWEAK-Fn14 axis in lupus, a disease related to autoimmunity and fibrosis.
Xu Y; Wei HT; Jing HY; Tan XY; Zhou XT; Ma YR
Int J Rheum Dis; 2022 Jan; 25(1):21-26. PubMed ID: 34716660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
